Shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) have earned an average recommendation of “Buy” from the six research firms that are currently covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokerages that have issued ratings on the […]
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) Director Arthur A. Levin sold 5,000 shares of the stock in a transaction that occurred on Friday, April 19th. The shares were sold at an average price of $22.82, for a total transaction of $114,100.00. Following the completion of the sale, the director now owns 14,830 shares […]
Avidity Biosciences, Inc. (NASDAQ:RNA) Receives Average Recommendation of "Buy" from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Avidity Biosciences (NASDAQ:RNA – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at Needham & Company LLC in a note issued to investors on Thursday, Benzinga reports. They presently have a $35.00 price objective on the biotechnology company’s stock. Needham & Company LLC’s target price indicates a potential upside of 129.36% […]
Avidity Biosciences' (RNA) "Buy" Rating Reaffirmed at Chardan Capital themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.